Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Novartis AG
Sep 02, 2019
Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings
Aug 16, 2019
Global Communicable Disease Market Research Report 2019 Featuring Abbott Laboratories, AbbVie., GlaxoSmithKline, Novartis and Pfizer
Jul 30, 2019
Global Vision Care Market Size, Trends and Forecast Report 2019-2023 with Profiles of Bausch Health Companies, Johnson & Johnson, Novartis, The Cooper Companies
Jun 03, 2019
Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials
Jun 01, 2019
Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial
May 24, 2019
FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer
May 24, 2019
AveXis Announces Innovative Zolgensma® Gene Therapy Access Programs for US Payers and Families
May 13, 2019
The Global Rickets Treatment Market to 2023; Led by F. Hoffmann-La Roche, Merck, Novartis, Pfizer, and Sanofi
May 07, 2019
New AveXis data at AAN showed long-term durability of Zolgensma® in patients with spinal muscular atrophy (SMA) Type 1
May 05, 2019
AveXis presented robust data at AAN demonstrating efficacy of Zolgensma® in broad spectrum of spinal muscular atrophy (SMA) patients
Apr 26, 2019
Global HDAC (histone deacetylase) Inhibitors Market to 2023 Featuring Celgene, Merck & Co, Novartis, Shenzhen Chipscreen Biosciences, & Spectrum Pharmaceuticals
Apr 15, 2019
Novartis announces FDA filing acceptance and Priority Review of brolucizumab (RTH258) for patients with wet AMD
Mar 29, 2019
Global Antidiuretic Drugs Market 2019-2023 with Avadel, CSL Limited, Ferring B.V., Novartis & Sanofi Dominating
Mar 27, 2019
Novartis receives FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease
Feb 19, 2019
Alcon Debuts iLux® MGD Treatment System for Personalized Therapy for Dry Eye Disease at SECO International 2019 Annual Meeting
Jan 08, 2019
Novartis investigational therapy crizanlizumab (SEG101) receives FDA Breakthrough Therapy designation for the prevention of vaso-occlusive crises in sickle cell disease
Dec 06, 2018
Novartis investigational BYL719 (alpelisib) plus fulvestrant consistently improved PFS in patients with PIK3CA mutated HR+/HER2- advanced breast cancer in new SOLAR-1 analyses
Dec 02, 2018
Real-world data show Novartis drug Promacta® improves outcomes for ITP patients compared to other second-line therapies
Dec 01, 2018
Novartis announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
Nov 11, 2018
New Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patients
‹‹
Page 2
››
Latest News
Apr 25, 2024
The Spaceport Company Signs Agreement with Maritime Launch to Provide Tracking and Telemetry Stations for...
Apr 25, 2024
Intevac Announces First Quarter 2024 Financial Results
Apr 25, 2024
Expro Group Holdings N.V. Announces First Quarter 2024 Results
Apr 25, 2024
Laser Photonics’ Laser Technology Meets Unique Cleaning Needs of Precision Optics Manufacturers
Apr 25, 2024
LiveWire Group, Inc. Reports 2024 First Quarter Financial Results
Apr 25, 2024
LSI Industries Reports Fiscal 2024 Third Quarter Results and Declares Quarterly Cash Dividend
Apr 25, 2024
Janus International Group to Report First Quarter 2024 Results on May 9, 2024
Apr 25, 2024
Trane Technologies Recognized as One of Europe’s Climate Leaders by Financial Times
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events